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Transient Receptor Potential (TRP) cations channels, as key regulators of intracellular
calcium homeostasis, play a central role in the essential hallmarks of cancer. Among the
multiple pathways in which TRPs may be involved, here we focus our attention on the
ones involving small guanosine triphosphatases (GTPases), summarizing the main
processes associated with the metastatic cascade, such as migration, invasion and
tumor vascularization. In the last decade, several studies have highlighted a bidirectional
interplay between TRPs and small GTPases in cancer progression: TRP channels may
affect small GTPases activity via both Ca2+-dependent or Ca2+-independent pathways,
and, conversely, some small GTPases may affect TRP channels activity through the
regulation of their intracellular trafficking to the plasma membrane or acting directly on
channel gating. In particular, we will describe the interplay between TRPC1, TRPC5,
TRPC6, TRPM4, TRPM7 or TRPV4, and Rho-like GTPases in regulating cell migration, the
cooperation of TRPM2 and TRPV2 with Rho GTPases in increasing cell invasiveness and
finally, the crosstalk between TRPC1, TRPC6, TRPM8, TRPV4 and both Rho- and Ras-
like GTPases in inducing aberrant tumor vascularization.
Keywords: transient receptor potential channels, small guanosine triphosphatases, cancer hallmarks, metastasis,
molecular signaling, migration, invasion, tumor vascularizationINTRODUCTION
Ca2+ signaling plays a central role in the regulation of many important cellular functions and
indeed, not surprisingly, a dysregulation of Ca2+ homeostasis has been observed in various
pathological conditions, including tumorigenesis (Monteith et al., 2017). Changes in Ca2+Abbreviations: EC, endothelial cell; ECM, extracellular matrix; EGF, epidermal growth factor; EMT, epithelial to
mesenchymal transition; ER, endoplasmatic reticulum; FA, focal adhesion; FAK, focal adhesion kinase; GAP, GTPases
activating protein; GEF, guanine exchange factor; GDI, guanine-nucleotide dissociation inhibitors; GDP, guanosine
diphosphate; GTP, guanosine triphosphate; GTPase, guanosine triphosphatases; MLC, myosin light chain; MMP,
membrane-matrix metalloproteinases; PCa, prostate cancer; PI3K, phosphoinositide 3-kinase; PFGF, platelet-derived
growth factor; TEC, tumor endothelial cell; TRP, transient receptor potential; VEGF, vascular endothelial growth factor.
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alterations in the so-called “Ca2+-signaling toolkit” (Berridge
et al., 2003) which includes, among others, ion channels,
responsible for altered fluxes within the cell, and several Ca2+-
dependent effectors, which mediate various signal transduction
pathways in response to altered Ca2+ homeostasis.
In recent years, the involvement of Ca2+-permeable channels
in neoplastic diseases has been extensively investigated and a
direct correlation between their dysregulation and cancer
development has been shown (Monteith et al., 2017). Among
them, Transient Receptor Potential (TRP) channels have
revealed an important involvement in the regulation of many
signaling pathways associated with tumor progression (Yang and
Kim, 2020). One of the key features of TRP channels is their
polymodal activation mechanism and their involvement in
different signal transduction pathways. Among the multiple
pathways TRPs are signaling through, the ones involving
specific intracellular messengers belonging to the family of
small guanosine triphosphatases (GTPases) are emerging as
essential in tumorigenesis in the last decade. Therefore, in this
review, we will focus on the interplay between TRPs and small
GTPases, and its role in several aspects of the metastatic process
(Aspenström, 2004; Clayton and Ridley, 2020).
The metastatic cascade leads to spread of malignant cells from
the primary tumor through the lymph or blood circulation to
establish secondary growth in a distant organ; it is a multistep
process involving highly complex structural and functional
alterations within cancer cells. Primary tumor cells are primed
for dissemination by the process of epithelial-mesenchymal
transition (EMT), during which they assume a more aggressive
mesenchymal-like phenotype. This phenotypic switch allows them
to detach from the primary tumor mass and to acquire migratory
and invasive properties, in order to move from their original
location, migrate and invade the extracellular matrix (ECM) and
endothelium to spread to secondary sites and form metastases
(Roche, 2018). All the steps involved in metastatic cascade (EMT,
cell migration, invasion and tumor vascularization) are regulated
by the intracellular Ca2+ concentration (Berridge et al., 2003) and
specifically by the TRP-mediated calcium influx (Fels et al., 2018),
as well as by the most important small GTPases (Rho-like and
Ras-like) involved in cytoskeletal dynamics and cell polarity
(Ungefroren et al., 2018). Here, we discuss TRPs and small
GTPases contribution in cancer progression, focusing on
signaling pathways involving a direct interplay between TRPs
and small GTPases in three main metastatic cancer hallmarks:
migration, invasion and tumor vascularization.
TRP Channels
TRP channels mainly act as signal transducers by altering
membrane potential or intracellular Ca2+ concentration in
response to various environmental stimuli, including physical-
chemical stimuli, such as temperature, pH changes, osmolarity,
and pressure as well as endogenous and exogenous ligands (Nilius
and Owsianik, 2011). TRP channels have been shown to play a
central role in carcinogenesis as well as in various late stages of
tumor progression. In particular, it has been shown that changes inFrontiers in Pharmacology | www.frontiersin.org 2the expression of TRP channels are correlated with the progression
of different types of cancer. To date, most changes involving TRP
proteins do not involve mutations in the TRP gene but rather
dysregulation of the wild-type TRP protein expression levels,
depending on the stage of cancer (Gkika and Prevarskaya, 2011;
Lehen’kyi and Prevarskaya, 2011; Bernardini et al., 2015;
Shapovalov et al., 2016). Moreover, several recent studies have
highlighted a direct correlation between cancer patient survival
and TRP channel expression. Tumor differential expression of the
main TRP channels discussed in this review and its correlation with
patients’ survival are summarized in Table 1.
These observations strongly indicate that TRPs play a significant
role in cancer progression and more specifically in many processes
underlying the metastatic cascade, making them promising
candidates as both molecular biomarkers and therapeutic targets
in various types of cancer (Gkika and Prevarskaya, 2011; Fiorio Pla
and Gkika, 2013; Bernardini et al., 2015; Lastraioli et al., 2015; Litan
and Langhans, 2015; Fels et al., 2018). It has been shown that TRP-
mediated effects on metastatic cancer cell behavior are mainly
associated to their Ca2+ permeability. Indeed, through the
regulation of intracellular Ca2+ concentration, both in the cytosol
and within subcellular organelles, TRP channels play a key role in
many Ca2+-dependent signaling pathways, including those
associated with the metastatic cascade such as EMT, migration,
invasion and tumor vascularization (Iamshanova et al., 2017). In
response to different environmental challenges during the metastatic
cascade, like hypoxic, acidic and mechanical cues, cancer cells “re-
program” TRPs expression and “misuse” their functions in order to
put in place and sustain a more aggressive, metastatic phenotype.
However, although most of the TRP-mediated pathways involved in
cancer progression are due to alteration of Ca2+ homeostasis, it has
been also demonstrated an involvement of these channels
independent from their Ca2+ permeability. As an example,
TRPM7 regulation on cell migration is mainly due to Mg2+ influx
through the channel (Abed and Moreau, 2009; Su et al., 2011).
Similarly, the Na+-selective TRPM4 channel has been implicated in
cancer migration, although it is inherently Ca2+-impermeable
(Vennekens and Nilius, 2007; Cáceres et al., 2015; Holzmann
et al., 2015). On the other hand, TRPs’ involvement in the
metastatic cascade may also be pore-independent, extending the
interest in TRPs beyond the field of ion channels (Vrenken et al.,
2015). Indeed, TRPM7 promotes many of its biological effects
through its peculiar intrinsic kinase activity (Desai et al., 2012;
Faouzi et al., 2017; Cai et al., 2018). Moreover, we recently
demonstrated the role of TRPM8 in inhibiting vascular
endothelial cell migration, which is independent from the pore
function of the channel (Genova et al., 2017).
It is therefore evident that, despite the countless advances made in
recent years in the study of TRP channels, there are still many aspects
to be explored in order to better characterize the main TRP-mediated
pathways involved in tumor progression and thus be able to develop
new cancer therapies that use TRPs as therapeutic targets.
Small GTPases
The family of small GTPases is composed of a large group of
structurally and functionally related proteins, subgrouped intoSeptember 2020 | Volume 11 | Article 581455
Chinigò et al. TRPs-Small GTPases Interplay in Metastasissix families: Ras, Rho, Arf, Rab, Ran, and RGK. Among them,
Ras-like and Rho-like GTPases are the most well characterized.
Mechanistically, small GTPases are molecular switches that cycle
between an active GTP- bound form and an inactive GDP-bound
form. More specifically, these enzymes, once bound to GTP, can
catalyse its hydrolysis to GDP and this reaction then results in a
conformational change which causes the inactivation of the
proteins (Vetter and Wittinghofer, 2001; Cherfils and Zeghouf,
2013). The cycling between GTP- and GDP-bound states is
tightly regulated by specific GTPases activating protein
(GAPs), which act as negative regulators, promoting the GDP-
bound state by increasing the hydrolysis activity of small
GTPases, and by guanine exchange factors (GEFs), which act
as positive regulators, guiding the replacement of the hydrolysed
GDP for a GTP, thus promoting the enzyme active state (Mishra
and Lambright, 2016). Moreover, a third family of regulatory
proteins called guanine-nucleotide dissociation inhibitors
(GDIs) inhibits small GTPases activity by controlling theirFrontiers in Pharmacology | www.frontiersin.org 3intracellular localization: GDIs bind to GTPases in their
inactive GDP-bound state and sequester them in the cytosol,
thus preventing their translocation to intracellular membranes,
where activation occurs (Mishra and Lambright, 2016). Indeed, it
has been shown that spatial and temporal distributions of the
different small GTPases, as well as of their regulators, are
important determinants in signaling by small GTPases,
determining many aspects of cell behavior (Yarwood et al.,
2006; Cherfi l s and Zeghouf , 2013 ; Moissoglu and
Schwartz, 2014).
The conformational changes following the binding to GTP allow
the association of small GTPases with a large number of potential
effector proteins such as enzymes and scaffold proteins, which
mediate the specific biological effects of each GTPases. Thanks to
their ability to interact with a wide number of downstream targets
and to co-ordinately activate several molecular processes required
for a particular cellular response, small GTPases function as
signaling switches in numerous cellular processes. In general, itTABLE 1 | TRPs expression in cancer and correlation with patient survival prognosis.










↑ poor Azimi et al., 2017;
Dhennin-duthille et al., 2011
TRPC5 Colon yes ↑ ↑ poor Chen et al., 2017a
TRPC6 Prostate yes ↑ ↑ Yue et al., 2009
Glioblastoma yes ↑ ↑ Chigurupati et al., 2010
Esophageal squamous cell carcinoma yes ↑ ↑ poor Zhang et al., 2013
Breast/Invasive ductal adenocarcinoma yes ↑ Guilbert et al., 2008; Dhennin-duthille et al., 2011
TRPM2 Breast yes ↑ ↑ Depends on
subtype
Sumoza-Toledo et al., 2016
TRPM4 Prostate yes ↑ Ashida et al., 2004; Singh et al., 2006
Cervical yes ↑ Narayan et al., 2007
TRPM7 Breast yes ↑ ↑ poor Middelbeek et al., 2012; Meng et al., 2013
Invasive ductal adenocarcinoma/lymph
nodes
yes ↑ ↑ Dhennin-duthille et al., 2011; Guilbert et al., 2013
Pancreatic ductal adenocarcinoma/lymph
nodes
yes ↑ ↑ poor Rybarczyk et al., 2012; Yee et al., 2015
Nasopharyngeal no ↑ ↑ poor Chen et al., 2015
Ovarian; Prostate; Melanoma; Sarcoma ↑ Meng et al., 2013
TRPM8 Breast ductal adenocarcinoma yes ↑ ↑ Dhennin-duthille et al., 2011
Prostate yes ↑ loss Tsavaler et al., 2001; Fuessel et al., 2003; Bidaux
et al., 2005
Urothelial carcinoma of bladder yes ↑ ↑ poor Xiao et al., 2014
Lung Very low level ↑ Tsavaler et al., 2001
Colon no ↑ Tsavaler et al., 2001
Melanoma no ↑ Tsavaler et al., 2001
Osteosarcoma yes ↑ ↑ poor Zhao and Xu, 2016








Caprodossi et al., 2008
Esophageal squamous cell carcinoma yes ↑ ↑ poor Zhou et al., 2014
Gastric yes ↑ ↑ poor Zoppoli et al., 2019
Breast (Triple negative/basal subtype) yes ↑ better Elbaz et al., 2018
TRPV4 Breast yes ↑ ↑ poor Lee et al., 2016; Lee et al., 2017
Gastric ↑ poor Lee et al., 2016
Ovarian ↑ poor Lee et al., 2016
Glioma yes ↑ ↑ poor Ou-yang et al., 2018↑: increment; ↓: reduction.September 2020 | Volume 11 | Article 581455
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regulating cell cycle, differentiation and proliferation, (Shields et al.,
2000), whereas Rho-like GTPases are mainly involved in cell
morphology, cytoskeletal dynamics and cell polarity (Ridley,
2001). Moreover, Rab GTPases play a key role in many cellular
functions, by controlling intracellular trafficking between organelles
through vesiculotubular carriers and thus ensuring the
spatiotemporal regulation of vesicle traffic (Stenmark, 2009).
Considering the central role of Ca2+ signaling in many of these
processes, it is not surprising that small GTPases activity was found
to be strongly related to Ca2+ homeostasis (Aspenström, 2004).
More specifically, their activation/inactivation may occur through
Ca2+-dependent mechanisms acting on specific GEF/GAP proteins
or directly on them.Moreover, some GTPases have revealed a direct
influence on calcium signaling by regulating the activity of certain
calcium channels, including TRPs, by itself or through their effectors
(Koopman et al., 2003; Aspenström, 2004; Iftinca et al., 2007; Correll
et al., 2008). Finally, several small GTPases collaborate with calcium
signaling through the activation of specific Ca2+-related effectors
involved in cellular processes, such as cell adhesion, cell migration
and exocytosis (Cullen and Lockyer, 2002; Aspenström, 2004; Bader
et al., 2004).
Small GTPases expression results dysregulated in several
tumors and has been correlated with the progression of the
disease (Sahai and Marshall, 2002; Svensmark and Brakebusch,
2019). Without a doubt, Ras is still the most studied small
GTPase in cancer, due to the role played by mutated ras genes
in the pathogenesis of human tumors (Bos, 1989; Hobbs et al.,
2016; Li et al., 2018). Indeed, oncogenic mutations on H-ras, K-
Ras, and N-Ras genes have been detected in several tumor types,
although the incidence varies greatly (Bos, 1989; Prior et al.,
2012; Li et al., 2018). Moreover, some members of the Ras
superfamily like Rap1, resulted involved in cancer hallmarks
such as migration and angiogenesis, due to their key role in
integrin-mediated “inside-out” signaling events (Chrzanowska-
wodnicka et al., 2008; Boettner and Van Aelst, 2009; Carmona
et al., 2009). As regards the Rho superfamily, its role in many
aspects of the metastatic cascade, including EMT, cell migration,
invasion and angiogenesis, has been well established (Bryan and
D’Amore, 2007; Ungefroren et al., 2018; Clayton and
Ridley, 2020).
TRPs-Small GTPases Interplay in
Metastatic Cancer
Migration
One of the key steps in the metastatic cascade involves the
acquisition of motility by cancer cells. This results from a
complex coordination between cytoskeleton dynamics, cellular
contractility and cell adhesion rearrangements. Cell migration is a
dynamic process characterized by the cycling of four principal steps:
after an initial phase in which cell spreading increases about twice
with the generation of protrusions at the leading edge and cell
adhesion to the ECM increases, then spreading is reduced and
thanks to the generation of traction forces cell compacts and
detaches at the trailing edge, allowing for cellular movement
(Haws et al., 2016). Due to their role as key regulators ofFrontiers in Pharmacology | www.frontiersin.org 4cytoskeletal dynamics and cell polarity, it is not surprising that
Rho GTPases play a central role in controlling cell migration
(Clayton and Ridley, 2020). This process is triggered by cell
acquisition of a front-rear end polarity due to the formation of
protrusive structures, called filopodia and lamellipodia, at the front
edge, opposite to a retracting trailing edge (Llense and Etienne-
Manneville, 2015). Filopodia consist of actin filaments organized as
long parallel bundles and their formation is dependent on Rho
GTPase Cdc42 activity, whereas lamellipodia result from the
subsequent Rho GTPase Rac1-mediated branching of actin
filaments. The extension of actin-based protrusions is
accompanied by the formation at the leading edge of new
adhesions that link integrins on the plasma membrane to the F-
actin cytoskeleton through talin, vinculin, and focal adhesion
kinases (FAKs) and which can mature into focal adhesions (FAs)
in a process Rho GTPase RhoA- dependent. Contemporary, RhoA
also mediates cytoskeletal rearrangements that lead to the formation
of stress fibers, structures composed of bundles of actin and myosin
II that have a high contractile capability. The force necessary to pull
the cell body forward is engendered by the association of mature
FAs with the end of stress fibers and by the actin-myosin
cytoskeleton contraction. Finally, the disassembly of FAs in the
rear of the migrating cells supports cell retraction at the trailing
edge, allowing for cell detachment and movement.
A direct involvement of TRP channels activity in all processes
associated with cell migration, including cytoskeletal rearrangement,
FA turnover and cellular contractility, has been well established
(Fiorio Pla and Gkika, 2013; Canales et al., 2019). Therefore, it is not
surprising that several studies have highlighted a tight interplay
between TRP channels and Rho GTPases in controlling cell
migration during cancer progression. As depicted in Figure 1,
this interplay is characterized by a bidirectional communication,
in which TRP channels promote actin cytoskeleton reorganization
through a cation-dependent activation of Rho GTPases, and,
conversely, some small GTPases cause changes in TRP channel
location, protein–protein interactions and channel gating, thereby
modulating their function. More specifically, as described in the
following paragraphs, TRPC5, TRPC6, TRPC1, TRPM7, TRPM4,
and TRPV4 have been found to affect cell migration through a
direct interaction with some small GTPases belonging to the
Rho family.
Indeed, TRPC5 and TRPC6 channels have been identified as
antagonist regulators of actin remodelling and cell motility in
fibroblast and kidney podocytes, mediating the activation of
Rac1 and RhoA, respectively (Tian et al., 2010). It has been
shown that TRPC5 and TRPC6 trigger antagonistic and mutually
inhibitory pathways associated with the maintenance of the
balance between contractility and motility. In particular,
TRPC5-mediated Ca2+ influx induces Rac1 activation, thereby
enhancing motility and cell migration. Conversely, TRPC6-
mediated Ca2+ influx stimulates an increase in RhoA
activation, thereby promoting stress fibers formation, cell
contractility and the subsequent inhibition of cell migration
(Tian et al., 2010) or the disruption of podocytes architecture
in glomerular renal diseases, which may lead to proteinuria
(Jiang et al., 2011). Interestingly, the functional couplingSeptember 2020 | Volume 11 | Article 581455
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gives rise to two distinct molecular complexes predominantly
localized to discrete membrane compartments, as detected by co-
immunoprecipitation and immunofluorescence (Tian et al.,
2010). Of note, the presence of constitutively active Rac1 has
been shown to affect TRPC5 channel localization, leading to an
increase in plasma membrane abundance of TRPC5 with respect
to TRPC6, which, conversely, is predominant in cells expressing
constitutively active RhoA. In this regard, RhoA seemed to have
no effect on the dynamics of TRPC6 insertion into the
membrane, whereas Rac1 was found to promote translocation
of TRPC5 into the plasma membrane, according to other
findings (Bezzerides et al., 2004). This close interdependence
between TRPC5 and Rac1 could suggest a positive feedback
mechanism in which the Rac1-mediated TRPC5 insertion from a
vesicular pool into the cell membrane leads to enhanced TRPC5-
mediated Ca2+ influx, which in turn triggers the activation of
Rac1 and the subsequent migratory phenotype. Although a direct
correlation between TRPC5/TRPC6 and Rac1/RhoA has not yet
been established in cancer models, it is possible to speculate that
a similar interplay may also occur in the regulation of cancer cells
migration, taking into account the evidence for direct
involvement of TRPC5 and TRPC6 in the increased migratory
potential of several cell types (Greka et al., 2003; Xu et al., 2006;
Rampino et al., 2007), including some tumors such as colon
cancer and glioblastoma (Chigurupati et al., 2010; Chen L. et al.
2017; Chen Z. et al., 2017). However, whether these effects on
tumormigration are dependent on the impact of TRPC5 and TRPC6
activity on cell contractility and motility remains to be clarified.Frontiers in Pharmacology | www.frontiersin.org 5Similarly, TRPC1 has shown a correlation with an increased
migratory phenotype in some tumors, such as glioblastoma,
osteosarcoma, thyroid, pancreatic and colon carcinoma (Dong
et al., 2010; Asghar et al., 2015; Huang et al., 2015; Guéguinou
et al., 2016; Lepannetier et al., 2016). One of the key steps in cell
migration is the establishment of a functional and morphological
polarity along the axis of movement. In this context, it has been
demonstrated that TRPC1 is localized to lipid raft domains at the
leading edge of migrating cells and plays a role in determining
their polarity and directionality (Fabian et al., 2008; Bomben
et al., 2011; Huang et al., 2015). For instance, it has been shown
that silencing of TRPC1 in transformed renal epithelial Madin–
Darby Canine Kidney-Focus (MDCK-F) cells leads to a decrease
in migration associated with a failure of cell polarization and
an impaired lamellipodia formation. This effect is due to
the partial loss of the local Ca2+ gradient at the front edge,
needed to establish and maintain the axis of movement in
migrating cells (Fabian et al., 2008). The same results were also
shown in U2OS bone osteosarcoma cells, in which TRPC1
inhibition or knockdown correlates with a decrease in the
percentage of polarized cells and the consequent reduction in
cell migration (Huang et al., 2015). However, the link between
TRPC1-mediated Ca2+ gradients and actin dynamics, as well
as the possible involvement of TRPC1-mediated Rho
GTPases activation in these processes has not been yet fully
characterized. Nonetheless, a direct interaction between TRPC1
and RhoA has been characterized in intestinal epithelial cells
(IECs) and in pulmonary arterial endothelial cells (Mehta et al.,
2003; Chung et al., 2015). Indeed, TRPC1-RhoA interactionFIGURE 1 | TRP- small GTPases signaling pathways interplay in cell migration. Cartoon depicting TRP channels signaling pathways affecting cell motility and
contractility through GTPases. TRPC5, TRPM4 and TRPV4 induce the formation of protrusions and spreading via Rac1 activation in a Ca2+-dependent manner and
at the same time Rac1 promote the translocation of TRPC5 into the plasma membrane; Rac1 and RhoA through SOCE activation induce TRPC1-mediated cell
polarization for directional cell migration; TRPM7 control polarized cell movement through the regulation of Rac1 and Cdc42 in a Mg2+-dependent way; TRPM7,
TRPV4, and TRPC6 contribute to actin dynamics and cell contractility through the Mg2+- or Ca2+-mediated activation of RhoA/ROCK pathways. FAK, focal adhesion
kinase; Akt, protein-kinase B; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; PDGF, platelet-derived growth factor; PDGFR, platelet-derived
growth factor receptor; Orai1, calcium release-activated calcium channel; SK3, small conductance calcium-activated potassium channel 3; STIM, stromal interaction
molecule 1; ROCK, Rho-associated protein kinase; a-SMA, alfa-smooth muscle actin; MLC, myosin light chain.September 2020 | Volume 11 | Article 581455
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stimulating IECs migration after wounding (Chung et al.,
2015). A reduction of RhoA/TRPC1 complexes, induced by
downregulation or inactivation of either small GTPase or TRP
channel, is associated with an inhibition of Ca2+ influx after store
depletion and the decrease in wound healing after injury (Chung
et al., 2015). Besides RhoA, a mechanism involving TRPC1 and
Rac1 in promoting colon cancer cell migration has recently been
proposed (Guéguinou et al., 2016). Indeed, in HCT-116 colon
cancer cells TRPC1 and Rac1 are involved in a complex positive
feedback loop in which EGF-induced SOCE activates both Rac1
and STIM1 through Akt pathway; in turn, STIM1 activation
promotes translocation of TRPC1 and Orai1 into lipid rafts
where SK3 is located and thereby triggers SOCE mediated by the
complex SK3/TRPC1/Orai1. At the same time, Akt-mediated
Rac1 activation enhances SOCE and thereby SOCE-dependent
cell migration through Akt pathway, with subsequent
lamellipodia formation and calpain activation. Taken together
these data suggest a direct interplay between TRPC1 and Rho
GTPases in controlling cell polarity and actin rearrangements
during cancer cell migration.
TRPM7 is involved in directional migration in different cell
types including migrating fibroblasts, osteoblasts, astrocytes and
endothelial cells (ECs) (Abed and Moreau, 2009; Wei et al., 2009;
Baldoli et al., 2013; Zeng et al., 2015). Similarly to TRPC1,
TRPM7 has been shown to be involved in Ca2+ gradient
formation, contributing to cell polarization and directional
migration (Wei et al., 2009). In particular, TRPM7 is positively
correlated with platelet-derived growth factor (PDGF)-induced
Mg2+ influx as well as high-calcium microdomains “Ca2+
flickers”, most active at the leading lamella of migrating cells
(Abed and Moreau, 2009; Wei et al., 2009). Interestingly, several
data have shown that the effects of TRPM7 in controlling
cytoskeleton and polarized cell movement are independent of
its kinase activity and are associated with its channel function.
This has been clearly demonstrated in fibroblasts and
neuroblastoma cells where re-expression of TRPM7, as well as
a kinase-inactive mutant of TRPM7 on knock out cells, reverted
phenotypic changes in cell polarization enhancing cell spreading
and adhesion (Clark et al., 2008; Su et al., 2011). In particular, it
has been shown that Mg2+ plays a central role in TRPM7-
mediated control of directional migration in fibroblasts and
osteoblasts (Abed and Moreau, 2009; Su et al., 2011). The
effects observed by TRPM7 depletion in cell morphology,
disruption of actin filaments and myosin fibers and a decrease
in the number of FAs, correlates with decreased activity of RhoA
GTPase, suggesting a role for TRPM7 in RhoA regulation (Su
et al., 2011). Besides its interaction with RhoA, TRPM7 is also
functionally coupled with Rac1 and Cdc42: indeed, TRPM7
knockdown prevents Rac1 and Cdc42 activation, with a
subsequent deficiency in their ability to form lamellipodia and
impaired polarized cell movements (Su et al., 2011). Although
Rho GTPases, differing from Ras and Rab proteins, do not
require Mg2+ for high-affinity nucleotide binding, it has been
shown that Mg2+ plays a role in regulating nucleotide binding
and hydrolysis kinetics in the GEF- and GAP-catalyzed reactionsFrontiers in Pharmacology | www.frontiersin.org 6of Rho family GTPases (Zhang et al., 2000). In particular,
RhoGAPs exploit Mg2+ to achieve high catalytic efficiency and
specificity and, conversely, RhoGEFs are negatively regulated by
free Mg2+, since the presence of Mg2+ significantly decreases the
intrinsic dissociation rates of the nucleotides. This finding may
suggest that one role of GEFs is to displace bound Mg2+ from
Rho proteins in order to efficiently perform their function and
dissociate nucleotide from Rho GTPases (Zhang et al., 2000).
Taken together this data revealed an interesting and so far little
investigated interplay between TRP channel and Rho GTPases in
controlling cell migration mediated by Mg2+ homeostasis.
More recently, another member of the TRPM subfamily,
TRPM4, has been recognized as the first TRP channel to be
part of the adhesome that is the set of protein components of FAs
required for migration and contractility (Cáceres et al., 2015).
Indeed, it has been shown that TRPM4 localises to FAs in
different cell types and that its suppression impaires FAs
relocation and lamellipodia formation, leading to a reduced
cellular spreading and migration in mouse embryonic
fibroblasts. Actually, FA turnover plays a key role in cell
migration, contributing to the generation of the traction
forces necessary for cellular movements. TRPM4-mediated
effects on cell migration are at least partially due to the
activation of Rac1 GTPase. Indeed, it has been observed that
upon silencing TRPM4 the serum-induced activation of Rac1
and lamellipodial distribution are significantly reduced,
suggesting a direct cooperation between TRPM4 and Rac1 in
the regulation of cellular spreading. Moreover, it has been
demonstrated that TRPM4 pharmacological inhibition caused
retarded skin wound healing in vivo, affecting cell contractility
(Cáceres et al., 2015). TRPM4 has been found to affect the
migratory behaviour of many cell types, including prostate
cancer cells (Holzmann et al., 2015). Although TRPM4 itself is
Ca2+-impermeable, its contribution to cell migration through the
regulation of intracellular Ca2+ signaling has been well established
(Vennekens and Nilius, 2007). For instance, in androgen-insensitive
prostate cancer cells, it has been shown that TRPM4 acts as an
important negative feedback regulator of SOCE, thus promoting cell
migration (Holzmann et al., 2015). However, further investigations
are needed to deepen the knowledge of the molecular mechanism
underlying the pro-migratory effect of TRPM4 on prostate cancer
cell migration.
To date, several experimental pieces of evidence have revealed
a critical role of TRPV4 in regulating the migratory properties of
many tumors, including liver, breast and gastric cancer (Vriens
et al., 2004; Lee et al., 2016; Xie et al., 2017). However, little is
known about the molecular mechanism driving this process.
Nonetheless, it has been shown that TRPV4 is involved in the
dynamics of trailing adhesions, likely through an interplay with
other cation channels or proteins present at the FA sites
(Mrkonjić et al., 2015). A direct correlation between TRPV4
and RhoA/ROCK pathways has been revealed in cardiac
fibroblast remodelling and myofibroblast contraction. In
particular, it has been shown that after stimulation with
growth factors, TRPV4 contributes to cell contractility by
increasing the actin protein a-SMA expression and incorporationSeptember 2020 | Volume 11 | Article 581455
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ROCK pathways (Tomasek et al., 2006; Adapala et al., 2013;
Thodeti et al., 2013). Another study reported a role of TRPV4 in
the modulation of adherent-junctions, mediated by the TRPV4-
dependent activation of Rho GTPases, thereby promoting actin
fibers organization and junctions formation (Sokabe and
Tominaga, 2010). Furthermore, the exogenous up-regulation of
TRPV4 in breast cancer has been shown to aid actin dynamics
and lead to higher activation of cofilin, a downstream protein
effector of RhoA/ROCK pathways that promotes actin filaments
depolymerisation, thus conferring cellular “softness” and
promoting transendothelial migration (Lee et al., 2016).
Accordingly, TRPV4 knockdown reduced migration, invasion
and transendothelial migration in breast cancer cells (Lee et al.,
2016). Finally, a recent study of Ou-yang and co-worker (Ou-
yang et al., 2018) has described the Akt/Rac1 signaling pathway
through which TRPV4 promotes migration and invasion in
glioma cancer cells (Ou-yang et al., 2018). Mechanistically,
agonist-mediated TRPV4 activation promoted the activation of
Rac1 by targeting Akt for phosphorylation, thus enhancing
glioma cell migration and invasion (Ou-yang et al., 2018).
Accordingly, in gastric cancer, TRPV4-mediated Ca2+ influx
promotes cell migration through the activation of the
downstream Akt/b-catenin pathways (Xie et al., 2017).
Collectively, these data support a direct interplay between
TRPV4 and small GTPases in controlling cytoskeletal
remodeling aimed to confer migratory phenotypes.
Invasion
In order to reach lymph- and bloodstreams and to colonize sites
distant from the primary tumor, cancer cells have to acquire,
beyond migratory phenotype, the ability to degrade ECM.
Consequently, invasion is another key step of the metastatic
cascade. Invasiveness of cancer cells comes from their ability to
produce special protrusions called invadopodia, which are actin-rich
protrusions of the plasma membrane with proteolytic activity. Once
matured, invadopodia recruit proteolytic enzymes such as
membrane-matrix metalloproteinases (MMPs), which are
endopeptidases able to locally degrade ECM, allowing cell
invasion. Among them, MMP-2 and MMP-9 are considered the
most important in metastasis, since they were often aberrantly
expressed in tumors (Jabłońska-trypuć et al., 2016). Both TRP
channels and small GTPases have been implicated in increased
tumor invasiveness through the induction of MMPs expression
(Betson and Braga, 2003; Yang and Kim, 2020). Indeed, TRPM2,
TRPM7, TRPM8, TRPV2, and TRPC1 have shown to cause
upregulation of MMP9 in a Ca2+-dependent manner in gastric,
bladder, oral squamous, prostate and thyroid cancer cells
respectively (Monet et al., 2010; Okamoto et al., 2012; Asghar
et al., 2015; Cao et al., 2016; Chen L. et al. 2017; Chen Z. et al.,
2017; Almasi et al., 2019). Additionally, TRPM2, TRPM7, and
TRPC1 activity have been also correlated withMMP2 production in
gastric, lung, pancreatic and thyroid cancer (Asghar et al., 2015;
Rybarczyk et al., 2017; Liu et al., 2018; Almasi et al., 2019). On the
other hand, Rho and Rac GTPases activation has been correlated
with increased MMPs expression in different cancer cell typesFrontiers in Pharmacology | www.frontiersin.org 7(Zhuge and Xu, 2001; Abécassis et al., 2003; Santibáñez et al.,
2010; Jacob et al., 2013).
TRPV2 and TRPM2 have been shown to affect cell
invasiveness through signaling pathways involving small
GTPases, which are summarized in Figure 2.
In particular, TRPV2 has been found to positively correlate with
prostate cancer (PCa) invasiveness, promoting PCa progression to
the aggressive castration-resistant stage (Monet et al., 2010). More
specifically, it has been shown that siRNA-mediated silencing of
TRPV2 leads to a decrease in MMP-2 and MMP-9 expression,
reducing growth and invasive properties of PC3 prostate tumors
established in nude mice xenografts (Monet et al., 2010). The
mechanism by which the Ca2+ influx mediated by TRPV2 is
linked with the up-regulation of MMPs has not been
characterized. However, another study has revealed that TRPV2
trafficking to the plasma membrane correlates with enhanced cell
migration and invasion in PCa, via the phosphoinositide 3-kinase
(PI3K) pathway (Oulidi et al., 2013). Taking into account evidence
of a PI3K-mediated activation of Rac1 in several tumor models
(Haws et al., 2016; Ungefroren et al., 2018) and considering that
Rac1 has been found to regulate TRPV2 intracellular trafficking in
fibrosarcoma cells (Nagasawa and Kojima, 2015), it is possible to
speculate that in PCa a PI3K-mediated Rac1 activation may allow
the translocation to the plasma membrane of the “de novo”
expressed TRPV2 in PC3 cells, thus giving rise of the TRPV2-
mediated increase of cytosolic Ca2+ concentration responsible for
MMPs overexpression. Confirming this hypothesis, Rac1 has been
related to the up-regulation of MMP-2 andMMP-9 in fibrosarcoma
(Zhuge and Xu, 2001) and transformed keratinocytes (Santibáñez
et al., 2010), respectively. Unlike in PCa, TRPV2 has been found to
suppress the invasiveness of fibroblast-like synoviocytes (FLS),
which have an aggressive and invasive behaviour resembling that
of cancer cells (Laragione et al., 2015). TRPV2 activation has been
associated both in vitro and in vivo with reduced cell invasiveness
and a down-regulation of the IL-1b-induced expression of MMP-2
and MMP-3 (Laragione et al., 2015). More recently, the cell
signaling events mediating this TRPV2 suppressive activity have
been characterized (Laragione et al., 2019). Interestingly, a direct
interplay between TRPV2 channel function and RhoA/Rac1
GTPases activity in suppressing FLS cell invasion has been
proposed (Laragione et al., 2019). In particular, it has been shown
that, upon stimulation with the commercially-available TRPV2-
specific agonist O1821, the channel nearly disappears from the
plasma membrane, as well as integrins an, b1, and b3, involved in
cell binding to ECM. Concomitantly, a decrease in cell adhesion and
the number of thick actin filaments and a reduction in lamellipodia
formation are observed. Mechanistically, it has been found that
O1821-induced TRPV2 activation causes a decrease in both RhoA
and Rac1 activation, giving rise to the observed inhibition of actin
filaments and lamellipodia formation, respectively. Moreover,
TRPV2 activation significantly increases levels of phosphorylated
(inactive) cofilin and affects the localization of active cofilin keeping
it in the cytosol away from cell protrusions and lamellipodia, in
which normally it exerts its function on actin remodeling, upon
activation by Rac1. Considering the active involvement of Rac1 in
TRPV2 trafficking found by Nagasawa and Kojima (2015), Rac1September 2020 | Volume 11 | Article 581455
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explain the observed reduction of TRPV2 expression on the plasma
membrane after channel stimulation, suggesting an intriguing
negative feedback loop between TRPV2 and Rac1 regulation.
Indeed, TRPV2 activation on the plasma membrane may inhibit
in a Ca2+-dependent manner Rac1 activation, which in turn resulted
in a decrease of TRPV2 expression on the cell surface. Taken
together these data account for a possible two-sided interplay
between Rac1 and TRPV2, based on which TRPV2 may exert
both pro- and anti-invasiveness activities depending on cell type. In
the first case Rac1 is activated by the PI3K pathway, thus allowing
the overexpression of the constitutively active TRPV2 on the plasma
membrane and the increased calcium flow responsible for MMPs
overexpression and the increased cell invasiveness (Nagasawa and
Kojima, 2015); in the second case TRPV2, upon activation by
external stimuli, causes Rac1 inactivation and the inhibition of pro-
invasive intracellular pathways as well as the expression of TRPV2
in the membrane through a negative feedback mechanism
(Laragione et al., 2019). Therefore, in an interesting interchangeable
relationship, TRPV2 may act as either modulator or effector of Rac1,
depending on cell type, thus reflecting the bivalent activity showed by
the channel in cell invasiveness.
TRPM2 offers another potential field of investigation on TRP-
small GTPase relationship in cancer cells’ ability to invade
surrounding tissues. In fact, it has been recently proven that
TRPM2 causes an increase in MMP-9 production in gastric
cancer (Almasi et al., 2019). As in the case of TRPV4, the
function of TRPM2 appears to be regulated by the Akt
pathway, known to regulate the activity of several GTPases
including Rac1 (Ho et al., 2010), whose interaction with
TRPM2 has been already well established in response to
oxidative stress (Gao et al., 2014) (Figure 2). In this regard, it
has been demonstrated that TRPM2 and Rac1 physically interactFrontiers in Pharmacology | www.frontiersin.org 8with each other, mutually influencing their activity, similarly to
what was observed between TRPC5 and Rac1 in podocytes
previously described (Bezzerides et al., 2004; Tian et al., 2010).
Thus, we could speculate a TRPM2-Akt-Rac1 axis in the
modulation of MMP-9 expression in gastric cancer.
Tumor Vascularization
Tumor vascularization, is a critical step in the metastatic cascade
since the formation of new blood vessels is crucial not only to
provide sufficient oxygen and nutrients and thus promoting the
continuous growth of tumors but also to drive tumor spread and
metastasis. Tumor vascularization, promoted by the tumor cells
themselves through the secretion of several growth factors,
results aberrant and leads to the formation of new vessels
characterized by abnormal morphology, irregular blood flow,
and distribution, non-uniform pericyte coverage and hyper-
permeability (Carmeliet and Jain, 2000; Carmeliet and Jain,
2011). TRP channels are widely expressed within vascular ECs
and several data correlate aberrant TRP channels expression
and/or activity with tumor vascularization, thanks to their high
sensitivity to both pro-angiogenic signals and subtle changes in
the local microenvironment (Brossa et al., 2019; Negri et al.,
2020; Scarpellino et al., 2020). TRP channels have been related to
critical steps of tumor vascularization, including cell adhesion,
cell migration, enhanced permeability and in vitro angiogenesis
(Fiorio Pla and Gkika, 2013). Similarly, several Rho and
Ras small GTPases, thanks to their contribution to actin
dynamics, cell contractility and integrin-mediated “inside-out”
signaling events, have been found to be dysregulated during
tumor vascularization (Carmona et al., 2009; Chrzanowska-
Wodnicka, 2010). Some common pathways involving both
TRP channels and small GTPases in determining aberrant
tumor vascularization have been described, such as thoseFIGURE 2 | TRP- small GTPases signaling pathways interplay in cell invasion. Cartoon depicting TRP channels signaling pathways affecting cell invasiveness
through GTPases. Rac1 promotes the translocation of TRPV2 into the plasma membrane and thus TRPV2-mediated increased in MMPs expression; TRPV2 affects
also cell adhesion and invasion interfering with integrin-mediated signalling and inhibiting Rac1, RhoA, and cofilin activation by Rac1 in a Ca2+-dependent manner;
TRPM2 and Rac1 physically interact with each other, mutually influencing their activity and lead to an increase in MMPs production; MMPs exocytosis is mediated by
the Rab superfamily of small GTPases. GF, growth factor; GFR, growth factor receptor; PI3K, phosphoinositide-3 kinase; Akt, protein-kinase B; MMP, membrane-
matrix metalloproteinase; ECM, extracellular matrix.September 2020 | Volume 11 | Article 581455
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Figure 3.
TRPV4 has been the first TRP channel to be clearly implicated in
tumor angiogenesis, although it can have both pro-angiogenic and
anti-angiogenic effects depending on tumor type. In particular,
TRPV4-mediated Ca2+ signals are implicated in tumor-derived
endothelial cells (TECs) migration via a membrane-stretch
activated arachidonic acid release and subsequent actin
remodeling and TRPV4 insertion in the plasma membrane
(Fiorio Pla et al., 2012). These data are in accordance with
previous results showing that TRPV4 is required for shear stress
EC reorientation in an integrin-dependent manner (Thodeti et al.,
2009). However, in different TECs models, TRPV4 results to be
down-regulated as compared to normal tissues. Moreover, this
down-regulation is correlated with aberrant mechano-sensitivity
of TECs towards ECM stiffness and subsequently with enhanced cell
motility and abnormal angiogenesis. Subcutaneous injection of
Lewis Lung Carcinoma cells in TRPV4 knockout mice leads to
increased vascular density, higher vessel diameter, and reduced
pericyte coverage, overall resulting in enhanced tumor growth
(Adapala et al., 2016). More recently, it has also been shown by
the same group that TRPV4 silencing causes a significant decrease
in VE-cadherin expression at cell-to-cell junctions, with the
subsequent increase in vascular leakage (Cappelli et al., 2019).
Accordingly, overexpression or pharmacological stimulation of
TRPV4 with GSK1016790A has been shown to lead to a
“normalization” of the vascular endothelium, enhancing the
permeability of chemotherapeutic drugs, and basically blocking
tumor growth (Adapala et al., 2016). In particular, TRPV4-
mediated “normalization” of aberrant capillary-like tubules in
vitro is achieved by restoring the mechano-sensitivity of ECsFrontiers in Pharmacology | www.frontiersin.org 9toward ECM stiffness through the blockade of basal Rho activity
(Adapala et al., 2016). In this contest, it was previously shown that
the aberrant TECs mechano-sensitivity of TECs in response to
ECM stiffness and cyclic strain results, at least partially, due to
constitutively high level of Rho/ROCK basal activities (Ghosh et al.,
2008). Moreover, ECs isolated from TRPV4 knockout (KO) mice
display higher basal Rho activity as compared to EC WT and the
inhibition of the Rho/ROCK pathway in TRPV4KO mice results in
vessel normalization, confirming the role of TRPV4 as an important
modulator of Rho activity also in vivo (Thoppil et al., 2016).
In agreement with other recent findings which have
highlighted non-conducting functions of TRP channels in
many processes, including the regulation of cytoskeletal
dynamics (Vrenken et al., 2015), our recent study (Genova
et al., 2017) has unveiled that TRPM8 inhibits ECs migration
in a Ca2+-independent manner. TRPM8 is mainly localized in
the endoplasmatic reticulum (ER) in ECs and its expression
results remarkably down-regulated in breast TECs (BTECs) as
compared to healthy human microvascular ECs (HMECs) and
human umbilical vein ECs (HUVECs) (Genova et al., 2017).
Mechanistically, TRPM8 inhibits ECs migration and spheroid
sprouting by trapping Rap1 intracellularly, thereby preventing its
relocation toward the plasma membrane, which is required to
activate b1-integrin signaling. Inactive Rap1 (GDP- bound)
physically interacts with the N-terminal tail of TRPM8 and
interestingly, its retention within the cytosol occurs also in the
presence of a TRPM8 pore mutant, demonstrating that TRPM8
inhibitory effects on ECs migration and adhesion by trapping
Rap1 are independent from its channel function (Genova et al.,
2017). Curiously, TRPM8 activation through specific channel
agonists (icilin and menthol) or endogenous activators such asFIGURE 3 | TRP- small GTPases signaling pathways interplay in aberrant tumor vascularization. Cartoon depicting TRP channels signaling pathways affecting tumor
vascularization through GTPases. TRPV4 induces aberrant mechano-sensivity to ECM through the Ca2+-dependent inhibition of Rho/ROCK pathway; TRPC1 and
TRPC6 enhance vessels permeability affecting cell contractility through a Ca2+-mediated regulation of RhoA; on the contrary, TRPM8 exerts a protective role in tumor
vasculature permeability, inhibiting the store-operated RhoA activation and subsequent cell contraction; TRPM8 also inhibits ECs adhesion and migration, impairing
activation of b1-integrin through the intracellular retention of Rap1. VE-cadherin, vascular E-cadherin; FAK, focal adhesion kinase; ROCK, Rho-associated protein
kinase; MLC, myosin light chain; PKCa, protein kinase C alpha; IP3R, inositol trisphosphate receptor; PAR-1, protease-activated receptor-1.September 2020 | Volume 11 | Article 581455
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of active Rap1-GTP bound and enhanced its inhibitory effect on
migration, thus raising questions about the possible effects of
agonists on TRPM8 besides pore gating. TRPM8-mediated
inhibition of Rap1 cytoplasm–plasma membrane trafficking
impairs the activation of inside-out signaling pathway known
to trigger the conformational activation of b1-integrin and,
consequently, cell adhesion and migration. Indeed, icilin-
stimulated TRPM8 significantly inhibits active-b1 integrins as
revealed by immunofluorescence assays. In addition, agonist-
induced TRPM8 stimulation leads to a significant decrease in
FAK phosphorylation, suggesting the involvement of FAK as a
downstream effector of the b1-integrin pathway affected by
TRPM8 (Genova et al., 2017). This study has highlighted how
TRP channels may regulate GTPases activity not only by the
generation of local Ca2+ fluxes, but also acting through physical
interactions which affect their intracellular localization and thus
their activity. Indeed, as well as TRP channels, also small
GTPases are used for spatial and temporal control of cell
behavior, as reported by several studies (Yarwood et al., 2006;
Wang et al., 2012; Moissoglu and Schwartz, 2014). Another
evidence of a TRPM8 interplay with small GTPases in controlling
ECs behavior comes from a study of Sun and coworkers (Sun et al.,
2014), which has revealed a role of TRPM8 in vasoconstriction
and hypertension through attenuating RhoA/Rho kinase pathway.
In particular, the authors have shown that TRPM8 activation
by menthol attenuates vasoconstriction by inhibiting the RhoA/
ROCK pathway in wild-type mice, but not in TRPM8KOmice (Sun
et al., 2014). TRPM8 effect is associated with inhibition of
intracellular calcium release from the sarcoplasmic reticulum, thus
reducing Ca2+-mediated activation of RhoA/ROCK and ECs
contraction. Since several experiments have correlated ECs
contraction with vessel permeability (Hicks et al., 2010), this
study could suggest a protective role of TRPM8 not only in ECs
migration, but also in tumor vasculature permeability.
The increased permeability shown by tumor vessels may be
induced by several factors, including hypoxia and inflammatory
signals, such as thrombin. In this regard, TRPC6 and TRPC1 have
been implicated in thrombin-induced hyper-permeabilization of
ECs through the RhoA/ROCK signaling pathway. Thrombin is a
serine-protease which binds specifically to the protease-activated
receptor-1 (PAR-1) on endothelial cell surface, inducing a signaling
cascade, which results in an increase in ECs contraction, changes in
cell shape and finally, in the development of tiny inter-endothelial
junctional gaps that lead to increased endothelial permeability.
Interestingly, TRPC6 activation is promoted by thrombin
stimulation through the a subunit of G protein-coupled receptors
(Gaq) (Singh et al., 2007). Then, TRPC6-mediated Ca2+ influx leads
to the activation of PKCa and thereby induces RhoA activity and
ECs contraction, with subsequent cell shape changes, inter-
endothelial gaps formation and increase in EC permeability
(Singh et al., 2007). Indeed, upon thrombin stimulation it has
been shown that RhoA activates its downstream effector ROCK,
which in turn promotes myosin light chain (MLC) phosphatase
regulatory subunit phosphorylation, reducing its phosphatase
activity (Birukova et al., 2004). TRPC6 have also been found toFrontiers in Pharmacology | www.frontiersin.org 10play a central role in determining the angiogenic potential of glioma
cells, since its inhibition affected EC tube formation in vitro by
reducing the number of branch points (Chigurupati et al., 2010).
Moreover, TRPC6 has been shown to exert pro-angiogenic effects
by affecting vascular endothelial growth factor (VEGF)-induced
calcium influx in ECs. Although there are not robust data on
GTPases-mediated TRPC6 functions in angiogenesis, recently
Zahra and coworkers defined an important role of RhoA in ECs
proliferation, migration, invasion and sprouting triggered by
important angiogenesis inducers, including VEGF (Zahra et al.,
2019), thus suggesting a possible interplay between TRPC6 and
RhoA in VEGF-induced angiogenesis.
Similarly to TRPC6, also TRPC1 has been found to have a role
in increasing ECs permeability through RhoA activation in
response to thrombin stimulation. In this regard, an intriguing
mechanism depicting RhoA as a TRPC1 modulator in human
pulmonary arterial endothelial cells has been proposed by Mehta
and co-worker (Mehta et al., 2003). They showed that RhoA, upon
thrombin-induced activation, forms a complex with IP3R and
TRPC1, which then translocates to the plasma membrane, where
TRPC1 can mediate a store depletion-induced Ca2+ entry and the
resultant increase in endothelial permeability. Moreover, it has
been demonstrated that RhoA-induced TRPC1-IP3R association is
dependent on actin filament polymerization, since its inhibition
hinders both the association and Ca2+ entry (Mehta et al., 2003).
Moreover, TRPC1 serine/threonine phosphorylation by PKCa is
crucial for inducing Ca2+ influx and consequently EC permeability
(Ahmmed et al., 2004). However, the mechanism by with PKCa
integrates with RhoA in ECs to trigger TRPC1-mediated Ca2+
influx remained to be characterized. Nonetheless, considering the
previously described role of PKCa as a downstream effector of
TRPC6 (Singh et al., 2007), it is possible that the PKCa-
dependent RhoA-induced TRPC1 activation gives rise to a
positive feedback loop that overall leads to a persistent increase
endothelial permeability. This study provides an example of
pathway in which small GTPases do not act as TRP Ca2+-
dependent effectors, but rather as modulators of TRP channel
activity, influencing protein-protein interactions and channel
gating, and thus corroborating the bidirectional nature of this
complex interplay.
Conclusions and Perspectives
TRPs and small GTPases show a direct interplay in cancer
progression, characterized by a bidirectional communication,
whereby TRP channels have been shown to affect small GTPases
activity via both Ca2+-dependent or Ca2+–independent pathways,
and conversely some small GTPases may affect TRP channels
activity through the regulation of their intracellular trafficking to
the plasma membrane or acting directly on channel gating
(Table 2). In most cases, TRP-GTPase interaction is mediated by
Ca2+ signals, triggered by TRP-mediated Ca2+ influx through the
plasma membrane induced by growth factors, specific ligands or
mechanical stimuli. In some specific cases, such as TRPM7, TRP-
mediated small GTPases activation/inhibition may be supported by
Mg2+ rather than Ca2+ homeostasis regulation. Moreover, also
Ca2+-impermeable TRP channels like TRPM4 have been found toSeptember 2020 | Volume 11 | Article 581455
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control on other Ca2+-signaling pathways. Finally, alternative
regulatory pathways that go beyond the canonical ones involving
cation homeostasis have been characterized for TRP-mediated small
GTPases regulation. For instance, it has been shown that some
TRPs, such as TRPM8 in ECs, may act similarly to a GDI-like
protein, inhibiting small GTPases activity by physically trapping
and restraining them within a specific cellular compartment and
thus preventing their switch to the active form that generally occurs
at the plasmamembrane. Although in most cases small GTPases act
as TRP effectors, there are some evidence about the role of small
GTPases as modulators of TRP channel activity. Indeed, it has been
shown that some small GTPases may affect TRPs channel activity
by influencing channel trafficking, gene expression, protein-protein
interactions and channel gating. In some cases, positive feedback
loop mechanisms, wherein TRP channels activate small GTPases
which in turn increase TRPs insertion to the plasma membrane,
have also been described. In addition, some studies have highlighted
that effector/modulator roles may be interchangeable between TRPs
and small GTPases depending on cell type. For instance, it has been
shown that Rac1 may act as either modulator or effector of TRPV2
activity, thus determining opposite effects on cell invasion,
depending on cell type.
In addition to the examples of a direct TRP-small GTPases
interaction in metastatic cancer hallmarks reported in this review,Frontiers in Pharmacology | www.frontiersin.org 11many studies suggest other possible signal transduction pathways
associated with tumor progression involving both TRPs and small
GTPases. For instance, they have both been implicated in the
regulation of MMPs production through pathways like IP3K/Akt
and Hsp90a-uPA-MMP2 that offer many points of contact in
between them (Koike et al., 2000; Zhuge and Xu, 2001; Yang
et al., 2015; Luo et al., 2016; Rybarczyk et al., 2017; Liu et al.,
2018). However, to date, a direct correlation between TRPs and
small GTPases in these signal transduction pathways has not yet
been established but remains to be deeper clarified. Moreover,
several studies have reported a role of both these two
superfamilies of molecules in promoting another key step of the
metastatic cascade that is EMT. In response to the same growth
factor/cytokines-induced signaling pathways both TRPs and small
GTPases are able to induce the up-regulation of mesenchymal-like
markers such as vimentin and the down-regulation of epithelial-like
markers such as E-cadherin through the direct regulation of
transcriptional factors including STAT3, Snail and Twist (Simon
et al., 2000; Davis et al., 2014; Liu et al., 2014; Yang et al., 2015;
Chen L. et al., 2017; Kim et al., 2018 Liu et al., 2019; Seiz et al., 2020).
However, a synergistic cooperation between TRPs and Rho
GTPases during the early stage of growth-factor induced EMT is
still only speculation, since to the best knowledge of the authors a
direct correlation between TRPs and small GTPases effects on EMT
has not yet been characterized. In conclusion, the interplay betweenTABLE 2 | TRPs-small GTPases relationship in metastatic cancer hallmarks.
Hallmark TRP Channel GTPase Biological Effect Reference
Migration TRPC1 Ca2+
←
RhoA ↑ (Mehta et al., 2003; Chung et al., 2015)
Ca2+
↔
Rac1 ↑ (Guéguinou et al., 2016)
TRPC5 Ca2+
↔
Rac1 ↑ (Bezzerides et al., 2004; Tian et al., 2010)
TRPC6 Ca2+
!
RhoA ↓ (Tian et al., 2010)
TRPM4 Rac1 ↑ (Cáceres et al., 2015)
TRPM7 Mg2+
!





(Su et al., 2011)
TRPV4 Ca2+
!
RhoA ↑ (Tomasek et al., 2006; Adapala et al.,




Rac1 ↑ (Ou-yang et al., 2018)
Invasion TRPM2 Ca2+
↔
Rac1 ↑ (Gao et al., 2014)





↓ (Laragione et al., 2019)
Aberrant tumor
vascularization
TRPC1  RhoA ↑ (Mehta et al., 2003)
TRPC6 Ca2+
!
RhoA ↑ (Singh et al., 2007)
TRPM8 ┤ Rap1 ↓ (Genova et al., 2017)
┤ RhoA ↓ (Sun et al., 2014)
TRPV4 ┤ Rho ↓ (Thoppil et al., 2016; Adapala et al., 2016)Sep!: TRP enhances GTPase activity; ←: GTPase enhance TRP activity; ↔: bidirectional activation; ┤: TRP inhibits GTPase activity; ↑: increase; ↓: decrease.tember 2020 | Volume 11 | Article 581455
Chinigò et al. TRPs-Small GTPases Interplay in MetastasisTRP channels and small GTPase in cancer progression is only
partially investigated to date and further investigations are required
to shed light on many other aspects of this interesting crosstalk in
cancer not well known.AUTHOR CONTRIBUTIONS
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